FDA Warns on Hepatitis C Drugs
The Food and Drug Administration is warning about the risk of reactivation of hepatitis B among patients who have had that disease and who are taking some prominent and expensive newer medicines for hepatitis C.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: FREE Source Type: news
More News: Food and Drug Administration (FDA) | Health | Hepatitis | Hepatitis B | Hepatitis C | Pharmaceuticals | Warnings